Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
University of Manchester · MRC Epidemiology Unit · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
708
total citations
- FWCI
- 32.56
- Percentile
- 100%
- References
- 30
Citations per year
Authors
7- WGWilliam G DixonCorresponding
University of Manchester, MRC Epidemiology Unit
- KLKimme L Hyrich
University of Manchester, MRC Epidemiology Unit
- KWKath Watson
University of Manchester, MRC Epidemiology Unit
- MLMark Lunt
University of Manchester, MRC Epidemiology Unit
- JGJames Galloway
University of Manchester, MRC Epidemiology Unit
Topics & keywords
Topics
Keywords
- Medicine
- Adalimumab
- Infliximab
- Etanercept
- Rheumatoid arthritis
- Internal medicine
- Rheumatology
- Tuberculosis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.